{
    "address": "Dag Hammarskjolds Vag 52 A",
    "city": "Uppsala",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W7S922112",
    "description": "Q-linea AB is a holding company, which engages in the development of inventive systems for in vitro diagnostics for infectious diseases. The company is headquartered in Uppsala, Uppsala and currently employs 111 full-time employees. The company went IPO on 2018-12-07. The firm develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The firm's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). The company measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. The company is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.",
    "employeeTotal": "111.0",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Health Care",
    "ggroup": "Health Care Equipment & Services",
    "gind": "Health Care Equipment & Supplies",
    "gsector": "Health Care",
    "gsubind": "Health Care Equipment",
    "ipo": "2018-12-07",
    "isin": "SE0011527845",
    "logo": "https://finnhub.io/api/logo?symbol=QLINEA.ST",
    "marketCapitalization": 4666.996,
    "naics": "Scientific Research and Development Services",
    "naicsNationalIndustry": "Research and Development in Biotechnology",
    "naicsSector": "Professional, Scientific, and Technical Services",
    "naicsSubsector": "Professional, Scientific, and Technical Services",
    "name": "Q Linea AB",
    "phone": "46184443610.0",
    "sedol": "BGNM190",
    "shareOutstanding": 29.537947,
    "state": "UPPSALA",
    "ticker": "QLINEA.ST",
    "weburl": "https://www.qlinea.com"
}